We are live on
!
Find out more
CIBC Asset Management Portfolio holdings
AUM
$45.6B
1-Year Est. Return
44.74%
This Fund
S&P 500
This Quarter
Est. Return
-7.15%
1 Year Est. Return
+44.74%
3 Year Est. Return
+112.06%
5 Year Est. Return
+130.24%
10 Year Est. Return
+357.85%
AUM
$22.8B
AUM Growth
-$1.88B
(-7.6%)
Cap. Flow
-$292M
Cap. Flow
% of AUM
-1.28%
Top 10 Holdings %
Top 10 Hldgs %
31.02%
Holding
1,328
New
59
Increased
624
Reduced
198
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$80.7M |
| 2 |
Restaurant Brands International
QSR
|
+$50.6M |
| 3 |
UnitedHealth
UNH
|
+$44.6M |
| 4 |
Pfizer
PFE
|
+$40.7M |
| 5 |
Medtronic
MDT
|
+$39.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Scotiabank
BNS
|
+$181M |
| 2 |
Toronto Dominion Bank
TD
|
+$90M |
| 3 |
Royal Bank of Canada
RY
|
+$82.2M |
| 4 |
Enbridge
ENB
|
+$72.2M |
| 5 |
Fortis
FTS
|
+$70M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.33% |
| 2 | Energy | 12.22% |
| 3 | Technology | 10.43% |
| 4 | Industrials | 9.35% |
| 5 | Miscellaneous | 7.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Sarepta Therapeutics
SRPT
$2.28B
| $14M | 0.06% |
126,975
+123,961
| +4,113% | +$12.5M |
|
177
Micron Technology
MU
$1.06T
| $13.9M | 0.06% |
277,130
+13,007
| +5% | +$754K |
|
178
Zoetis
ZTS
$31B
| $13.6M | 0.06% |
91,419
+4,583
| +5% | +$766K |
|
|
RVNC
179
DELISTED
Revance Therapeutics, Inc.
RVNC
| $13.5M | 0.06% |
+501,169
| New | +$10.2M |
|
180
Stryker
SYK
$124B
| $13.5M | 0.06% |
66,558
+10,006
| +18% | +$2.1M |
|
181
Goldman Sachs
GS
$303B
| $13.5M | 0.06% |
45,954
+3,952
| +9% | +$1.28M |
|
182
Southern Company
SO
$102B
| $13.4M | 0.06% |
196,524
+11,648
| +6% | +$882K |
|
183
Ascendis Pharma A/S
ASND
$16.4B
| $13.3M | 0.06% |
+129,064
| New | +$12.2M |
|
184
Dollar General
DG
$27.8B
| $13.2M | 0.06% |
54,915
-4,162
| -7% | -$1.03M |
|
185
Becton Dickinson
BDX
$51.2B
| $13.1M | 0.06% |
58,948
+1,236
| +2% | +$308K |
|
186
Truist Financial
TFC
$61.4B
| $12.9M | 0.06% |
296,796
+69,836
| +31% | +$3.36M |
|
187
Roper Technologies
ROP
$41.8B
| $12.7M | 0.06% |
35,270
+3,504
| +11% | +$1.43M |
|
188
Consolidated Edison
ED
$39.5B
| $12.7M | 0.06% |
147,727
+10,398
| +8% | +$1M |
|
189
Lam Research
LRCX
$399B
| $12.6M | 0.06% |
344,970
+15,500
| +5% | +$690K |
|
190
Cintas
CTAS
$81.7B
| $12.4M | 0.05% |
128,140
-399,184
| -76% | -$40.8M |
|
191
Caterpillar
CAT
$376B
| $12.3M | 0.05% |
75,045
+5,210
| +7% | +$952K |
|
192
TJX Companies
TJX
$148B
| $12.3M | 0.05% |
197,219
+11,392
| +6% | +$716K |
|
193
Enphase Energy
ENPH
$5.19B
| $12.2M | 0.05% |
43,921
+27,301
| +164% | +$7.36M |
|
194
Cigna
CI
$73.4B
| $11.8M | 0.05% |
42,595
+1,905
| +5% | +$536K |
|
195
Citigroup
C
$223B
| $11.8M | 0.05% |
283,356
+18,909
| +7% | +$934K |
|
196
Cameco
CCJ
$46.3B
| $11.8M | 0.05% |
441,085
-20,427
| -4% | -$523K |
|
197
Crown Castle
CCI
$31.9B
| $11.7M | 0.05% |
81,001
+5,162
| +7% | +$883K |
|
198
SSR Mining
SSRM
$7.95B
| $11.7M | 0.05% |
790,189
-7,854
| -1% | -$118K |
|
|
ERF
199
DELISTED
Enerplus Corporation
ERF
| $11.5M | 0.05% |
811,842
+20,665
| +3% | +$290K |
|
200
Public Storage
PSA
$58.1B
| $11.5M | 0.05% |
39,325
+683
| +2% | +$222K |
|
Similar funds
EP
CIBC Asset Management's Q3 2022 Portfolio in Review
As of Q3 2022, CIBC Asset Management held 1,328 positions worth $22.8B, down 7.6% from $24.7B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
CIBC Asset Management's Q3 2022 filing shows 59 new, 624 increased, 198 reduced and 78 closed positions. Its largest new stake was 10x Genomics: 335,406 shares worth $9.55M. The largest sale was Scotiabank, an estimated $181M.
By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 29% a quarter earlier, followed by Energy and Technology.
- CIBC Asset Management's largest Q3 2022 buy was 10x Genomics: 335,406 shares worth $9.55M.
- CIBC Asset Management added most to Johnson & Johnson in Q3 2022, an estimated $80.7M increase.
- CIBC Asset Management's biggest Q3 2022 reduction was Scotiabank, cutting an estimated $181M.
- CIBC Asset Management fully exited PENN Entertainment in Q3 2022, selling an estimated $574K.
- CIBC Asset Management's ten largest holdings make up 31% of its $22.8B portfolio in Q3 2022.
- CIBC Asset Management opened 59 new positions and closed 78 in Q3 2022.
- CIBC Asset Management's portfolio value fell 7.6% quarter-over-quarter to $22.8B.
Based on CIBC Asset Management's 13F filing for Q3 2022, filed 3 Nov 2022.